Remove 2015 Remove Finance Remove Pharmaceuticals Remove Technology
article thumbnail

The Globalization Backlash Is Reverberating Through Boardrooms

Harvard Business Review

In 2015, Global Trade Alert, an independent trade-monitoring group, cited at least 644 discriminatory trade measures imposed by the G20 economies with the U.S. Meanwhile the Institute of International Finance forecasted net capital flows for emerging markets in 2015 would be negative for the first time since 1988.

article thumbnail

What to Know About Doing Business in Iran

Harvard Business Review

sanctions are delaying these projects being financed. more competition to reduce consumer prices, sharing international best practices, technology transfer, public-private partnerships) needed to boost the economy’s health. However, remaining U.S. financial system for bank transactions related to Iran.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Many CEOs Aren’t Breakthrough Innovators (and That’s OK)

Harvard Business Review

We’ve found that CEOs of big pharmaceutical companies, for example, are more likely to have a background as company lawyers, salespeople, or finance managers, than one in medicine or pharmaceutical R&D. Pharmaceuticals. The data captured a 20-year period, from 1995 to 2014. Overall, it is a messy picture.

CEO 8
article thumbnail

7 Charts Show How Political Affiliation Shapes U.S. Boards

Harvard Business Review

Both Republicans and Democrats say the most effective board committee is audit/finance. Meanwhile, Democrats place greater importance on technology expertise and risk management. pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g.,